BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11814515)

  • 21. Foley catheter vs prostaglandin as ripening agent in pregnant women with premature rupture of membranes.
    Mackeen AD; Walker L; Ruhstaller K; Schuster M; Sciscione A
    J Am Osteopath Assoc; 2014 Sep; 114(9):686-92. PubMed ID: 25170038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research on regimens for early medical abortion.
    von Hertzen H
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):133-6, 150. PubMed ID: 10846322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Chen MJ; Creinin MD
    Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medical induced abortion].
    Bettahar K; Pinton A; Boisramé T; Cavillon V; Wylomanski S; Nisand I; Hassoun D
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1490-1514. PubMed ID: 27818118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medications Used in Evidence-Based Regimens for Medical Abortion: An Overview.
    Soon JA; Costescu D; Guilbert E
    J Obstet Gynaecol Can; 2016 Jul; 38(7):636-45. PubMed ID: 27591347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misoprostol in the prevention of postpartum hemorrhage.
    Mategrano VA; Gabay MP
    Ann Pharmacother; 2001 Dec; 35(12):1648-52. PubMed ID: 11793636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
    Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
    PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotec and the FDA.
    Gaskin IM
    Midwifery Today Int Midwife; 2013; (107):8-14. PubMed ID: 24133793
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical methods for cervical ripening before the removal of intrauterine devices in postmenopausal women: a systematic review.
    Hou SP; Chen OJ; Huang LH; Cheng LN; Teng YC
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):130-42. PubMed ID: 23497958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labor induction with misoprostol.
    Wing DA
    Am J Obstet Gynecol; 1999 Aug; 181(2):339-45. PubMed ID: 10454679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials.
    Hou SP; Fang AH; Chen QF; Huang YM; Chen OJ; Cheng LN
    Contraception; 2011 Sep; 84(3):214-23. PubMed ID: 21843683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial.
    Graziosi GC; Bruinse HW; Reuwer PJ; van Kessel PH; Westerweel PE; Mol BW
    Hum Reprod; 2005 Aug; 20(8):2340-7. PubMed ID: 15831508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward safe and effective medical abortion.
    Ewart WR; Winikoff B
    Science; 1998 Jul; 281(5376):520-1. PubMed ID: 9705721
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of misoprostol for cervical ripening.
    Katz VL; Farmer RM; Dean CA; Carpenter ME
    South Med J; 2000 Sep; 93(9):881-4. PubMed ID: 11005347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy.
    Hofmeyr GJ; Gulmezoglu AM
    Cochrane Database Syst Rev; 2000; (2):CD000941. PubMed ID: 10796223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Same-day cervical preparation with misoprostol prior to second trimester D&E: a case series.
    Maurer KA; Jacobson JC; Turok DK
    Contraception; 2013 Jul; 88(1):116-21. PubMed ID: 23352801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert: a systematic review and metaanalysis.
    Austin SC; Sanchez-Ramos L; Adair CD
    Am J Obstet Gynecol; 2010 Jun; 202(6):624.e1-9. PubMed ID: 20430362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misoprostol versus low-dose oxytocin for cervical ripening: a prospective, randomized, double-masked trial.
    Ferguson JE; Head BH; Frank FH; Frank ML; Singer JS; Stefos T; Mari G
    Am J Obstet Gynecol; 2002 Aug; 187(2):273-9; discussion 279-80. PubMed ID: 12193911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.